Asparaginase () is an enzyme which is used to treat acute lymphoblastic leukemia (ALL). It is marketed under the brand name Elspar®. It can be given intramuscularly or intravenously.
The rationale behind asparaginase is that it takes advantage of the fact that ALL cells are unable to synthesize the non-essential amino acid asparagine whereas normal cells are able to make their own asparagine. These leukemic cells depend on circulating asparagine. Asparaginase however catalyzes the conversion of L-asparagine to aspartic acid and ammonia. This deprives the leukemic cell of circulating asparagine.
More on [ Asparaginase ]

L-Asparaginase - Drug Digest - Information for patients in FAQ format.
| Scientists Reveal Missing Link In Human Evolution | |
| Next Video | |